Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC
Clinical trial NCT04768075 · COMPLETED
Trial details
- NCT number
- NCT04768075
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2026-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.